Metimmox Success Featured in the News
The Metimmox trial, which has been running at Norwegian hospitals (Akershus University Hospital, St. Olav’s University Hospital, Haukeland University Hospital,
Read moreThe Metimmox trial, which has been running at Norwegian hospitals (Akershus University Hospital, St. Olav’s University Hospital, Haukeland University Hospital,
Read moreThere is a lot of evidence to suggest anti-angiogenic treatment (treatments that stop new blood vessels from growing) might be
Read moreA group of Acredit members, led by Dr Sebastian Meltzer has published a new paper outlining that the higher the
Read moreNew research looking at the impact of tumor-derived extracellular vesicles (EVs) on the phenotype and function of monocytes has been
Read moreNew research looking at the differences in tumour blood flow between patients of different sexes has been published by Acredit’s
Read moreCMOR members Erta Kalanxi, Sebastian Meltzer and Anne Hansen Ree have published a new review article looking into the current
Read moreAcredit members Thale Dawn Patrick-Brown and Kjersti Flatmark have published a new paper on the prevalence and incidence of pseudomyxoma
Read moreAcredit’s Karianne Giller Fleten has published a paper entitled “Experimental treatment of mucinous peritoneal metastases using patient-derived xenograft models”. In
Read moreAn Editorial written by the Kroemer group from the Gustave Roussy Comprehensive Cancer Institute highlights the recent research by Anne
Read moreLead Acredit professors Anne Hansen Ree and Kjersti Flatmark have published a paper outlining the final results from the MetAction
Read more